Alfentanil for conscious sedation during colonoscopy

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Conscious sedation is commonly used in medical procedures.
• Meperidine and midazolam is a traditional regimen for conscious sedation.
• Alfentanil is a newer fentanyl derivative with rapid onset and offset of action.

Purpose of the Study:

• To compare the efficacy and safety of alfentanil, alone or with midazolam, against meperidine and midazolam for conscious sedation.
• To determine if alfentanil offers advantages over the traditional regimen in terms of patient outcomes and procedure ease.

Main Methods:

• A randomized controlled trial involving 35 subjects.
• Subjects were assigned to receive either alfentanil with placebo, alfentanil with midazolam, or meperidine with midazolam.
• Outcomes assessed included desaturation, need for supplemental oxygen, patient and colonoscopist assessments of tolerance and discomfort, procedure ease, recovery time, complications, electrocardiogram, and blood pressure.

Main Results:

• The alfentanil and placebo group experienced less desaturation and required supplemental oxygen less frequently compared to the other groups.
• No significant differences were observed between the groups regarding patient/colonoscopist assessments, procedure ease, recovery time, complications, or hemodynamic stability.
• Baseline evaluations did not predict the need for supplemental oxygen.

Conclusions:

• Alfentanil, with or without midazolam, does not provide advantages over the established meperidine and midazolam regimen for conscious sedation.
• The choice of sedative regimen did not impact overall patient tolerance, procedural outcomes, or recovery.
• Further research may be needed to explore specific patient populations or procedural contexts where alfentanil might offer benefits.